The Trump administration is moving to ease federal restrictions on marijuana, marking a significant shift in policy. The Justice Department has reclassified state-licensed medical marijuana as a less dangerous substance, aligning it closer to certain painkillers and potentially paving the way for expanded research into cannabis. This reclassification is seen as a historic move, with reports indicating that changes could be finalized soon. The administration is signaling a readiness to loosen regulations on medical marijuana, raising hopes for legalization and causing a surge in cannabis stocks. This policy shift has been welcomed by industry leaders and advocates, suggesting a new era in cannabis regulation.